Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group

被引：0
|
作者：
Fountzilas, E. [1 ]
Lalla, T. [1 ]
Karakatsoulis, G. [1 ]
Papazisis, K. [1 ]
Exarchos, K. [1 ]
Koumarianou, A. [1 ]
Nikolaidi, A. [1 ]
Binas, I. [1 ]
Mauri, D. [1 ]
Karageorgopoulou, S. [1 ]
Razis, E. [1 ]
Christopoulou, A. [1 ]
Boutis, A. [1 ]
Douganiotis, G. [1 ]
Zagouri, F. [1 ]
Stamatopoulou, S. [1 ]
Spathas, N. [1 ]
Tryfonopoulos, D. [1 ]
Psyrri, A. [1 ]
Koutras, A. [1 ]
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Data Off, Athens, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113954
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3LBA
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [21] CNS efficacy of trastuzumab deruxtecan in metastatic breast cancer: A single-institution, real-world analysis.
    Zhang, Xiaojie
    Yeung, Kay T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
    Reinisch, Mattea
    Bruzas, Simona
    Spoenlein, Jennifer
    Shenoy, Satyendra
    Traut, Alexander
    Harrach, Hakima
    Chiari, Ouafaa
    Cremer, Efsthatia
    Ataseven, Beyhan
    Gubelt, Lars
    Kuemmel, Sherko
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [23] Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase II study
    Fountzilas, G
    Tsavdaridis, D
    Kalogera-Fountzila, A
    Christodoulou, C
    Timotheadou, E
    Kalofonos, C
    Kosmidis, P
    Adamou, A
    Papakostas, P
    Gogas, H
    Stathopoulos, G
    Razis, E
    Bafaloukos, D
    Skarlos, D
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1545 - 1551
  • [24] Advanced stage mucinous epithelial ovarian cancer: The Hellenic cooperative oncology group experience
    Pectasides, D
    Fountzilas, G
    Aravantinos, G
    Kalofonos, HP
    Efstathiou, E
    Salamalekis, E
    Farmakis, D
    Skarlos, D
    Briasoulis, E
    Economopoulos, T
    Dimopoulos, MA
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 436 - 441
  • [25] Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer
    Santin, Alessandro D.
    Corr, Bradley R.
    Spira, Alexander
    Willmott, Lyndsay
    Butrynski, James
    Tse, Ka Yu
    Patel, Jilpa
    Mekan, Sabeen
    Wu, Tia
    Lin, Kai-Wen
    Kuo, Peiwen
    Dumbrava, Ecaterina E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (29)
  • [26] Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+Metastatic Breast Cancer: The DE-REAL Study
    Botticelli, Andrea
    Caputo, Roberta
    Scagnoli, Simone
    Pisegna, Simona
    De Laurentiis, Michelino
    Curigliano, Giuseppe
    Lambertini, Matteo
    Pantano, Francesco
    Palazzo, Antonella
    Paris, Ida
    Vernieri, Claudio
    Tedesco, Beatrice
    Giampaglia, Marianna
    Palleschi, Michela
    Ballatore, Zelmira
    Alesini, Daniele
    D'Auria, Giuliana
    Fabbri, Agnese
    Rossi, Luigi
    Verrazzo, Annarita
    Scafetta, Roberta
    Marinelli, Daniele
    Sposetti, Caterina
    Barberi, Vittoria
    Strigari, Lidia
    Marchetti, Paolo
    Santini, Daniele
    Fabi, Alessandra
    ONCOLOGIST, 2024, 29 (04): : 303 - 310
  • [27] Efficacy and safety of cyclin-dependent kinase 4/6 inhibitor in patients with advanced breast cancer: A real-world experience
    Peng, Tzu-Rong
    Chen, Jia-Hui
    Wu, Ta-Wei
    THORACIC CANCER, 2023, 14 (30) : 3012 - 3019
  • [28] Evaluation of clinical benefit of sacituzumab govitecan (SG) following enfortumab vedotin (EV) in advanced urothelial cancer (UC): Real-world experience.
    Vlachou, Evangelia
    Hahn, Noah M.
    Dabb, Alix
    Johnson, Burles Avner
    Lefande, M. Susan
    Hoffman-Censits, Jean H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [29] Interstitial Lung Disease Associated with Trastuzumab Deruxtecan in HER2D Metastatic Breast Cancer: a Real-world Experience
    Shaheen, A.
    Hayhurst, H.
    Omokhodion, O.
    Ayyad, A.
    CLINICAL ONCOLOGY, 2024, 36 (04) : E111 - E112
  • [30] Efficacy and safety of palbociclib in treatment of HR-positive advanced breast cancer patients: A single center real-world experience.
    Vaid, Ashok K.
    Sharma, Devender
    Wadhwa, Jyoti
    Sharma, Nagender
    Mishra, Saurabh
    Gautam, Dheeraj
    Sen, Ashok
    Raju, Anisha
    Yadav, Lavina
    Verma, Girdhar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345